DUBLIN, CA-Supergen Inc., a developer of cancer therapies, hassigned a 30,000-square-foot lease renewal at Dublin CorporateCenter. The transaction retains the pharmaceutical company’sheadquarters at the office campus through the end of 2015.
SuperGen is dedicated to the discovery and development of novelcancer therapeutics in epigenetic and cell signaling modulation.The company develops products through biochemical and clinicalproof of concept to partner for further development andcommercialization. Supergen tells GlobeSt.com that “we love thelocation and the fact that we were able to renew our lease at asignificant reduction from our initial lease rate was a doublebonus for us.” The initial lease was a 10-year lease signed in2000, and according to Supergen, “the rates were quite high at thetime.” He couldn’t provide any further information at thistime.
Tishman Speyer, owner of the building recently recommitted toits investment in Dublin Corporate Center, when itretired the property’s mortgage debt and earmarked significantfunds for future leasing and capital costs, as GlobeSt.com recentlyreported.
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
*May exclude premium content
Already have an account?
Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.